Impact of perfusion with Methylene Blue on perioperative bleeding in simultaneous pancreas kidney transplant recipients

Phase 1

• Conditions: Simultaneous Pancreas and Kidney Transplantation; Intraoperative Bleeding; Surgery - Surgical techniques; Renal and Urogenital - Kidney disease; Renal and Urogenital - Other renal and urogenital disorders; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12621000985886
• Lead Sponsor: Westmead Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-27
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

All donor pancreases used for a SPK transplant at Westmead Hospital and only participants who provide informed consent will be enrolled in the study.

Exclusion Criteria

Exclusion criteria is any patients with previous adverse reactions or anaphylaxis to Methylene Blue and those who are being re-transplanted.

Study & Design

• Study Type: Interventional
• Study Design: Not specified